Anzeige
Mehr »
Login
Samstag, 11.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Innocan Pharma News: Unfassbare Studie - LPT-Therapie bewahrt Patient vor dem Tod!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
120 Leser
Artikel bewerten:
(0)

SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of PAREXEL International Corporation - PRXL

BALA CYNWYD, PA / ACCESSWIRE / June 22, 2017 / The law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of PAREXEL International Corporation ("PAREXEL" or "the Company") (NASDAQ: PRXL - News) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Pamplona Capital Management ("Pamplona").

Click here to learn more: http://www.brodskysmith.com/cases/parexel-international-corporation-nasdaq-prxl/, or call: 877-534-2590. There is no cost or obligation to you.

Under the terms of the transaction, PAREXEL shareholders will receive only $88.10 in cash for each share of PAREXEL stock they own. The investigation concerns whether the Board of PAREXEL breached their fiduciary duties to shareholders and whether Pamplona is underpaying for the Company. The transaction may undervalue the Company and may not be in the PAREXEL shareholders best interests. For example, the price being paid by Pamplona is below an analyst price target of $90.00 per share.

If you own shares of PAREXEL stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA 19004, by visiting http://www.brodskysmith.com/cases/parexel-international-corporation-nasdaq-prxl/, or calling toll free 877-LEGAL-90.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

SOURCE: Brodsky & Smith, LLC

Lithium vs. Palladium - Ist das die Chance des Jahrzehnts?
Sichern Sie sich den kostenlosen PDF-Report! So können Sie vom Boom der Rohstoffe profitieren.
Hier klicken
© 2017 ACCESSWIRE
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.